Options
HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis
Date Issued
2022-01-27
Date Available
2024-01-19T16:08:08Z
Abstract
Combining the diverse expertise of clinical and scientific researchers from across Europe as well as patient representatives and pharmaceutical industry partners, the HIPPOCRATES consortium aims to characterize the molecular pathways underlying psoriatic arthritis in order to improve early diagnosis and precision treatment strategies for the disease.
Sponsorship
European Commission Horizon 2020
Other Sponsorship
Innovative Medicines Initiative 2 Joint Undertaking
European Federation of Pharmaceutical Industries and Associations
Type of Material
Journal Article
Publisher
Springer Science and Business Media LLC
Journal
Nature Reviews Rheumatology
Volume
18
Issue
3
Start Page
123
End Page
124
Language
English
Status of Item
Peer reviewed
ISSN
1759-4790
This item is made available under a Creative Commons License
File(s)
Loading...
Name
NRR-21-243 V2 - final edits_cleaned.OF.pdf
Size
199.07 KB
Format
Adobe PDF
Checksum (MD5)
b572f78687fc58922783779f3295d915
Owning collection
Mapped collections